Uroalerts Men's Health Weekly

October 28, 2025

Videos

Peer-to-Peer Clinical Conversations

Preoperative Urinary Retention and Its Effect on HoLEP Surgery Outcomes - Diana Lopategui

Alan Wine hosts Diana Lopategui to present a retrospective database analysis examining whether chronic urinary retention severity impacts HoLEP outcomes.

Patient Selection for Penile Implant Surgery - Tobias Köhler

Tobias Köhler

Tobias Köhler shares practical strategies for optimizing penile implant outcomes.

Beyond the Abstracts

Retroperitoneal Lymphadenectomy (RPLND) for the Treatment of Testicular Germ Cell Tumors-Open or Robotic? pro Open Surgery : RPLND in the Management of Testis Cancer - Beyond the Abstract

Immunohistochemical Expression of Nectin-4 and Potential Implications for Enfortumab Vedotin Therapy in Germ Cell Tumors of the Testis: A Preliminary Study - Beyond the Abstract

Conference Coverage

ESMO 2025: Discussion: Long-Term SAKK 01/10 Seminoma Outcomes and the ALPACA Avelumab Study

ESMO 2025: A Phase 2 Study of Avelumab in Locally Advanced or Metastatic Penile Cancer Patients Unfit for Platinum-Based Chemotherapy or Progressed on or after Platinum-Based Chemotherapy (ALPACA)

Articles

Editor Selected Abstracts and Commentaries

Male Infertility

Deep learning-based approach for sperm morphology analysis.

Identifying potential genetic biomarkers for sperm dysfunction through whole-genome sequencing.

Erectile Dysfunction

From Prototype to Clinical Practice: How to Validate Novel Instruments for Non-Invasive Erectile Dysfunction Diagnostics?

Assessing Causality between Obstructive Sleep Apnea and Erectile Dysfunction: A Bidirectional Mendelian Randomization Study.

Erectile function after laparoscopic versus robotic-assisted radical prostatectomy: A systematic review and meta-analysis.

Therapeutic Effect of Micro-Energy Treatment for Erectile Dysfunction: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.

BPH - Benign Prostatic Enlargement

Pre- and Periprocedural Imaging Predicts Technical but not Clinical Success of Prostatic Artery Embolization Using Non-spherical PVA Particles-Insights From the Prospective PROEMBO Trial.

Benign Prostatic Hyperplasia Procedures in Patients with Prostate Cancer:: What Do We Know?

Review of Current Guidelines and Innovations in Benign Prostatic Hyperplasia Evaluation and Management.

Medical Therapy for Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms.

Penile & Urethral Cancers

Penile cancer in French Guiana: Epidemiology, histopathology and clinical aspects.

Testicular Cancer

Testicular germ cell tumors and molecular biomarkers.

Comprehensive analysis of microRNA expression provides mechanistic insights into transcriptomic alteration in primary and metastatic testicular germ cell tumors.

Prevalence of Fertility Preservation Counseling and Sperm Cryopreservation Amongst Males with Testis Cancer.

Retroperitoneal Lymphadenectomy (RPLND) for the Treatment of Testicular Germ Cell Tumors-Open or Robotic? pro Open Surgery : RPLND in the Management of Testis Cancer - Beyond the Abstract

Prostate Cancer

Urodynamic Changes Following a Staged Trial of Sacral Neuromodulation in Patients With Detrusor Underactivity

Age-Specific racial disparities in the incidence of fatal prostate cancer: an analytic deconstruction.

Clinical Oncological Tolerance of Testosterone Replacement Therapy Over Two Years Among Patients With High-Risk or Very High-Risk Prostate Cancer Undergoing Radiotherapy.

Should MRI-invisible low-risk prostate cancer be managed differently? A retrospective study of upgrading risk and future intervention.

Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.

Genomic Alterations and Associated Outcomes in Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer treated with 177Lu-PSMA-617.

PACT is requisite for prostate cancer cell proliferation.

Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 Phase III study.

Lutetium-177 [177Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trial.

Comparison of oncologic outcomes following robot-assisted radical prostatectomy in high- and very high-risk prostate cancer based on the 2025 National Comprehensive Cancer Network risk stratification.

The intersection of race and adiposity in prostate cancer: a narrative review.

Disparities in MRI and TRUS for Prostate Cancer Detection: A Systematic Review and Meta-Analysis of 94,020 Cases - Beyond the Abstract

PSMAddition Data Show Novartis Pluvicto™ Delays Progression to End-Stage Prostate Cancer

Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with 177Lu-PSMA: A Retrospective, Single-Center Study - Beyond the Abstract

Prostate cancer diagnostics: evolution over 30 years and the impact of education level - a prospective population-based study.

CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatment.

Prostate-specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long-term survival.

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer.

Transcriptomic predictors of prostate cancer recurrence following focal cryotherapy: a pooled analysis of phase II trial and prospective cohort data.

Innovative Se-Flutamide Derivatives: Enhanced Activity Toward Androgen Receptor (AR)-Dependent and -Independent Prostate Cancer Cells.

Modelling of immune infiltration in prostate cancer treated with HDR-brachytherapy using Raman spectroscopy and machine learning.

Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial.

PSMA PET Evaluation with a Deep Learning Platform Compared with a Standard Image Viewer and Histopathology.

Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer.

Urinary quality of life in patients treated with prostate SBRT with intra-prostatic boost.

Longitudinal outcome prediction of prostate cancer patients on active surveillance using multiple instance learning.

Seven-Year PSA ≤ 0.2 ng/mL After High-Dose-Rate Brachytherapy Indicates Eligibility for Discontinuing PSA Surveillance in Prostate Cancer.

Multi-layer stratified oncology platform utilizing transcriptomics, prostate cancer organoids, and modeling of drug response.

Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2025 Digital Science Press, LLC